We are live on ! Find out more
CC

Centiva Capital Portfolio holdings

AUM $11.5B
1-Year Est. Return 31.97%
This Fund
S&P 500
This Quarter Est. Return
+16.9%
1 Year Est. Return
+31.97%
3 Year Est. Return
+65.13%
5 Year Est. Return
+86.06%
10 Year Est. Return
–
AUM
$11.5B
AUM Growth
-$2.1B
Cap. Flow
+$623M
Cap. Flow %
5.43%
Top 10 Hldgs %
30.4%
Holding
2,352
New
725
Increased
351
Reduced
527
Closed
565
Avg Time Held Equity + Options
1.5 quarters
Top 10 Avg Time Held Equity + Options
1.4 quarters
Top 20 Avg Time Held Equity + Options
2.5 quarters
Avg Time Held Equity only
1.1 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.5 quarters

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$66M
2
ARM icon
Arm
ARM
+$49.5M
3
EA icon
Electronic Arts
EA
+$35M
4
AAPL icon
Apple
AAPL
+$27.5M
5
PDD icon
Pinduoduo
PDD
+$24.7M

Sector Composition

Rank Sector Weight
1 Miscellaneous 80.29%
2 Technology 6.34%
3 Financials 3.82%
4 Communication Services 2.62%
5 Industrials 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RGNX icon
2151
Regenxbio
RGNX
$513M
– –
-100,000
Closed -$830K –
RH icon
2152
RH
RH
$2.21B
– –
-3,031
Closed -$424K –
RILY icon
2153
BRC Group Holdings
RILY
$209M
– –
-11,580
Closed -$84.8K –
RIVN icon
2154
Rivian
RIVN
$19.6B
– –
-73,393
Closed -$1.1M –
RMBS icon
2155
Rambus
RMBS
$11B
– –
-2,995
Closed -$258K –
RMD icon
2156
ResMed
RMD
$33B
– –
-1,338
Closed -$300K –
ROIV icon
2157
Roivant Sciences
ROIV
$25B
– –
-7,596
Closed -$210K –
ROIV icon
2158
PUT
Roivant Sciences
ROIV
$25B
– –
-25,000
Closed -$693K –
RYTM icon
2159
Rhythm Pharmaceuticals
RYTM
$6.18B
– –
-4,000
Closed -$348K –
SABR icon
2160
Sabre
SABR
$759M
– –
-38,686
Closed -$56.1K –
SATL icon
2161
Satellogic
SATL
$724M
– –
-16,204
Closed -$88.2K –
SES icon
2162
SES AI
SES
$297M
– –
-23,323
Closed -$22.4K –
SG icon
2163
Sweetgreen
SG
$1.17B
– –
-66,273
Closed -$344K –
SGHT icon
2164
Sight Sciences
SGHT
$494M
– –
-23,598
Closed -$89K –
SGHC icon
2165
SGHC Ltd
SGHC
$5.7B
– –
-62,685
Closed -$677K –
SGRY icon
2166
PUT
Surgery Partners
SGRY
$1.86B
– –
-254,400
Closed -$3.03M –
SHEL icon
2167
Shell
SHEL
$289B
– –
-16,169
Closed -$1.5M –
SHLD icon
2168
Global X Defense Tech ETF
SHLD
$6.36B
– –
-6,146
Closed -$435K –
SLNO icon
2169
DELISTED
Soleno Therapeutics
SLNO
– –
-101,234
Closed -$3.39M –
SMPL icon
2170
Simply Good Foods
SMPL
$923M
– –
-11,184
Closed -$160K –
SMR icon
2171
NuScale Power
SMR
$2.75B
– –
-17,219
Closed -$187K –
SNBR icon
2172
DELISTED
Sleep Number
SNBR
– –
-11,083
Closed -$19.9K –
SNDR icon
2173
Schneider National
SNDR
$5.53B
– –
-12,995
Closed -$343K –
SNN icon
2174
Smith & Nephew
SNN
$11.6B
– –
-20,386
Closed -$648K –
SON icon
2175
Sonoco
SON
$4.75B
– –
-14,928
Closed -$807K –

Similar funds

Centiva Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Centiva Capital held 2,352 positions worth $11.5B, down 15% from $13.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Centiva Capital deployed $623M of net new capital in Q2 2026, opening 725 new positions and adding to 351 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 319,957 shares worth $240M.

By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, down from 86% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Netflix, an estimated $66M trimmed.

  • Centiva Capital's largest Q2 2026 buy was iShares Core S&P 500 ETF: 319,957 shares worth $240M.
  • Centiva Capital added most to NVIDIA in Q2 2026, an estimated $141M increase.
  • Centiva Capital's biggest Q2 2026 reduction was Netflix, cutting an estimated $66M.
  • Centiva Capital fully exited Pinduoduo in Q2 2026, selling an estimated $24.7M.
  • Centiva Capital's ten largest holdings make up 30% of its $11.5B portfolio in Q2 2026.
  • Centiva Capital opened 725 new positions and closed 565 in Q2 2026.
  • Centiva Capital's portfolio value fell 15% quarter-over-quarter to $11.5B.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.